Uptake of chemicals in biota can occur through several mechanisms and can involve the dermis, gills, pulmonary surfaces or the gut. Bioconcentration is the net accumulation in an organism of a contaminant via water only. Biomagnification is an increase in concentration from one trophic level (e.g., prey) to the next (e.g., predator) attributable to the accumulation of a contaminant via food (Newman 2009).

During the years of steep economic growth (1955–1973), Japan experienced the tragic effects of environmental pollution in the form of Minamata disease (Harada 1995), so called because it was first observed in the inhabitants of the fishing village in Minamata, Japan. This was a devastating neurological disease in humans resulting from the consumption of fish containing bioaccumulated organic mercury compounds. In the Japanese Chemical Substances Control Law (Ministry of Economy, Trade and Industry [METI] 2003), bioaccumulation of chemicals in fish is an issue of great interest. Fish muscle is considered one of the important tissues when evaluating bioaccumulation potential because fish muscle is a primary source of protein for human consumption. There is strong evidence that hydrophobic substances reach equilibrium in the lipid fraction of different tissues of an organism (Bertelsen et al. 1998; Tietge et al. 1998; Gobas et al. 1999, as cited in Arnot and Gobas 2006). However, this knowledge relies heavily on bioconcentration factor (BCF) data, and there are few experimental data that compare the tissue distribution of chemicals taken up by different routes (e.g., via water or food). Nitrofen (log Kow 4.32, calculated by using Kowwin v. 1.68 [US Environmental Protection Agency]) is a chemical that is highly hazardous to aquatic organisms for which there is limited hazard data (Hazardous Substances Data Bank; http://www.toxnet.nlm.nih.gov). Our goal in this study was to clarify the uptake characteristics of nitrofen in carp (Cyprinus carpio L.) via water and food and to discuss its tissue distribution on the basis of lipid content.

Materials and Methods

Nitrofen (NIP; 2,4-dichloro-1-(4-nitrophenoxy) benzene) (100%; Wako Pure Chemical Industries Ltd., Japan) was selected as a test substance for the exposure tests. Hexachlorobenzene (HCB, 99.7%; Tokyo Chemical Industry Co., Ltd., Japan) was used as a reference substance for the dietary tests. Yearling carp were cultivated in our laboratory and acclimatized according to the Organization for Economic Co-operation and Development (OECD) test guideline (TG) 305 (OECD 1996). The lipid content of test fish was measured as described by Bligh and Dyer (1959). The body weights, lengths and lipid contents of test fish during the test period were 3.31–14.39 g, 6.5–10.8 cm and 3.52–5.59% (based on whole body wet weight), respectively (aqueous exposure) and 2.16–5.70 g, 5.7–7.6 cm and 4.57–5.84%, respectively (dietary exposure).

The aqueous exposure test was carried out by the procedures of the “Flow-through Fish Test” (OECD 1996). The nominal NIP concentrations were 5.0 μg L−1 (high level) and 0.5 μg L−1 (low level). The test tank was a 70 L glass tank; 52 fish were used for each test. The uptake period was 60 days, and the depuration period was 7 days. Test water was kept at 25 ± 2°C. Polyoxyethylene hydrogenated castor oil (HCO-40, Nikko Chemicals Co., Ltd., Japan) and N,N-dimethylformamide (DMF, Nacalai Tesque, Inc., Japan) were used to prepare the stock solution. NIP and HCO-40 (at 10 times the amount of NIP) were dissolved with DMF to prepare two concentrations of NIP stock solution: 200 mg L−1 for the high level and 20.0 mg L−1 for the low level. The stock solution for a control was set to the same HCO-40 and DMF concentrations as in the high-level NIP stock solution. The stock solution (at a flow rate of 0.04 mL min−1) was diluted by groundwater (1,600 mL min−1) from the premises of the authors’ laboratory.

Test water was analyzed six times during the exposure period (after 11, 12, 26, 39, 49 and 60 days). For gas chromatography–mass spectrometry (GC–MS) analysis, NIP in test water (20 mL for high level; 200 mL for low level) was extracted by solid-phase extraction, using a Sep-Pak C18 (Nihon Waters K. K., Japan), and dissolved in 2 mL hexane (Kanto Chemical Co., Inc., Japan). Test fish were individually analyzed in two groups of two fish each, five times during the uptake period (after 12, 26, 39, 49 and 60 days) and four times during the depuration period (after 1, 4, 5 and 7 days). At the end of the exposure period, an additional five fish were taken from the low-level exposure tank and dissected into dermis (including scale, fin, and gill), head, digestive tract, hepatopancreas, viscera and muscle. Each type of tissue from the five fish was pooled into a single combined sample for tissue-specific analysis. The whole fish and main fish tissue samples were shredded using a polytron (Kinematica, Bohemia, NY, USA), and 5 g of each fish sample (except for dermis, digestive tract, hepatopancreas and viscera which had less than about 5 g) was used for GC–MS analysis. All samples from test fish were homogenized in 15 mL acetonitrile. The supernatant obtained by centrifugation of the homogenized sample (7,000×g, 5 min) was brought to a volume of 25 mL with acetonitrile. One milliliter of the extract was evaporated to dryness and dissolved in 10 mL hexane. Both test water and test fish samples were analyzed by GC–MS using an instrument (QP2010; Shimadzu Co., Japan) equipped with an HP-5MS column (30 m × 0.25 mm; Agilent Technologies, Inc., Santa Clara, CA, USA). The column temperature was held at 50°C for 1 min, ramped to 300°C at 40°C/min and then held for 3 min. Ion monitoring was at m/z = 202. A kinetic BCF was calculated according to OECD TG 305 as follows (parameters for BCF calculation are shown in Table 1):

$$ {\text{BCF}}_{\text{k}} = {\text{K}}_{\text{uptake}} /{\text{K}}_{\text{total}} $$
(1)

where BCFk is a kinetic bioconcentration factor, Kuptake is uptake rate constants, Ktotal is overall elimination rate constants.

Table 1 Parameters used for calculation of bioconcentration factors (BCFs) for nitrofen (NIP) under high- and low-exposure conditions

The dietary exposure test was performed according to Anonymous (2004 a, b). The test tank was a 100 L glass tank; 110 test fish were used for each test. The uptake period was 10 days, and the depuration period was 15 days to obtain the elimination half-life of HCB as well as that of NIP. Other conditions were the same as for the aqueous exposure test.

The test diet was prepared as follows. NIP (500 mg for high level, 50.0 mg for low level) and HCB (50.0 mg for both levels) were co-dissolved in 50 mL acetone (Wako Pure Chemical Industries, Ltd.) to which 50 g of fish feed oil (Riken feed oil omega, Eiken Shoji Co., Ltd., Japan) was added. After thoroughly mixing this solution, the solvent was removed using a rotary evaporator. Four hundred fifty grams of fish pellet feed (particle size 0.4–0.9 mm, lipid content ≥3%; Nippon Formula Feed Manufacturing Co., Ltd., Japan) was added to the fish feed oil, mixed well and then dried under ambient conditions for about 24 h. The control diet was treated the same as the test diet but without NIP or HCB. The nominal concentrations of test substances in the test diet were 1,000 (NIP) + 100 μg g−1 (HCB) (high level) and 100 (NIP) + 100 μg g−1 (HCB) (low level). Food was added to the tanks at a feeding rate (I) of 0.03 g diet/g live fish/day and the fish were allowed to feed naturally. During the depuration period, the fish were fed the control diet. The lipid content of the test diets averaged from samples at the beginning and end of the uptake period were (mean ± SD) 15.5 ± 0.2% (high level), 15.4 ± 0.2% (low level) and 15.0 ± 0.3% (control).

For GC–MS analysis of the test diet, 1 g (n = 3) was homogenized with 15 mL hexane, and the supernatant obtained by centrifugation (7,000×g, 5 min) was brought to a volume of 25 mL with hexane. One milliliter of the hexane extract was diluted to 10 mL with hexane for GC–MS analysis. Test fish were analyzed individually in two groups of five fish each at the end of the uptake period (after 10 days) and five times during the depuration period (after 1, 5, 7, 9 and 15 days). At the end of the exposure period (after 10 days), an additional five fish were collected from the low-level test tank and dissected as in the aqueous exposure test. For GC–MS analysis, the test fish were treated using the same method as with the aqueous exposure test but using acetone for extracting NIP and HCB. NIP and HCB in both diet and fish tissue were measured using the same GC–MS conditions as described for the aqueous exposure test. Ion monitoring for HCB was at m/z = 283. BMF was calculated according to Anonymous (2004a) as follows (parameters for BMF calculation are shown in Table 2):

$$ {\text{alpha }}(\alpha ) \, = \, ({\text{C}}_{{0,{\text{fish}}}} \times {\text{K}}_{\text{total}} )/({\text{I}} \times {\text{C}}_{\text{diet}} )/( 1-{ \exp }(-{\text{K}}_{\text{total}} \times {\text{t}})) $$
(2)
$$ {\text{BMF }} = {\text{I}} \times \alpha /{\text{K}}_{\text{elim}} $$
(3)
$$ {\text{BMF}}_{\text{lipid}} = {\text{ BMF}}/{\text{F}} $$
(4)

where alpha (α) is calculated uptake efficiency of test chemical from diet, C0, fish is concentration in fish at the beginning of depuration derived from the regression line intercept, Ktotal is overall elimination rate constants, I is feeding rate, Cdiet is concentrations of test substance in the test diet, t is duration of uptake phase, BMF is biomagnification factor, Kelim is growth-corrected elimination rate constants, BMFlipid is lipid- corrected BMF and F is lipid corrected factor: fishlipid/dietlipid.

Table 2 Parameters used for calculation of biomagnification factors (BMFs) for nitrofen (NIP) and hexachlorobenzene (HCB) under high- and low-exposure conditions

Results and Discussion

There was no mortality in any exposed or control fish. The overall growth rates constants (during entire study) of fish in the aqueous exposure test were 0.0186 g d−1 (high level), 0.0186 g d−1 (low level) and 0.0188 g d−1 (control). The overall growth rates constants in the dietary exposure test were 0.0278 g d−1 (high level), 0.0291 g d−1 (low level) and 0.0265 g d−1 (control). There were no significant differences between growth rates at either exposure level for both tests (t test, p > 0.05).

The measured concentrations of NIP in the water of the aqueous exposure tests were 4.68 ± 0.32 μg L−1 (high level) and 0.466 ± 0.025 μg L−1 (low level). The BCFk was 5,100 (high level) and 5,100 (low level), BCFss was 5,400 (high level) and 4,700 (low level). The 5%-lipid normalised BCFk (BCFk, lipid) was 5,200 (high level) and 6,100 (low level). The concentration of NIP in tissues of fish (μg g wet wt−1) from the aqueous exposure test was highest in viscera, followed by head, hepatopancreas, digestive tract and dermis, with the lowest concentration in muscle (Table 3).

Table 3 Tissue concentrations and quantity of nitrofen (NIP) and hexachlorobenzene (HCB)

Concentrations of NIP in the test diet (Cdiet) were 1,000 ± 21 μg g−1 (high level) and 104 ± 6 μg g−1 (low level). The concentrations of HCB in the test diet were 96.7 ± 3.2 μg g−1 (high level) and 93.6 ± 2.4 μg g−1 (low level). The BMFlipid was 0.137 (high level) and 0.137 (low level). The concentration of NIP in tissues of fish from the dietary exposure test was highest in viscera, followed by hepatopancreas, head, digestive tract and dermis, with the lowest concentration in muscle (Table 3).

Test fish in the dietary exposure test were exposed to a complex diet containing both NIP and HCB, whereas, fish in the aqueous exposure test were only exposed to NIP. The use of a reference substance provides a check on the assimilation efficiency resulting from the method used to spike the diet, but the test substance and reference substance should not interact with each another (Anonymous 2004b). In this test, we observed high assimilation efficiencies (α) for HCB (0.717–0.733), which indicates a sufficient bioavailability of the spiked diet. HCB is generally not metabolized by fish and so should not affect the metabolic capacity of the fish. In fact, BMF parameters for HCB did not change under the different dosing concentrations of NIP in this test. Therefore, we conclude that the use of HCB did not affect the accumulation potential or the comparison of NIP distribution in tissue in this study.

Growth-corrected elimination half lives (t 1/2) were similar values between both exposure tests; 2.1–3.0 days via aqueous exposure and 2.7–2.9 days via dietary exposure. To compare the distributions of NIP and lipid content in tissues, we measured both the lipid and NIP content in the same group of fish. The comparison of percentage distributions on a whole-body basis is shown in Fig. 1. Despite the difference in uptake routes, the percentage of whole-body NIP found in muscle was almost the same for the two routes – 27% via aqueous exposure and 26% via dietary exposure. Furthermore, the distribution patterns of NIP and the lipid content of tissues on a percentage basis were similar – highest in the head, followed by muscle, viscera, dermis, digestive tract and hepatopancreas. There was no specific accumulation in the dermis or digestive tract, which were in direct contact with the NIP. We conclude that there is a strong relationship between tissue distribution of NIP and lipid content, independent of the uptake route. Our results provide laboratory data useful for environmental and human risk assessments.

Fig. 1
figure 1

Distribution of lipids and test substances in fish tissues on a whole-body basis. Value in column shows percentage distribution of test substances on a whole-body basis